全文获取类型
收费全文 | 4525篇 |
免费 | 308篇 |
国内免费 | 48篇 |
专业分类
耳鼻咽喉 | 99篇 |
儿科学 | 85篇 |
妇产科学 | 47篇 |
基础医学 | 681篇 |
口腔科学 | 92篇 |
临床医学 | 341篇 |
内科学 | 907篇 |
皮肤病学 | 169篇 |
神经病学 | 332篇 |
特种医学 | 390篇 |
外科学 | 701篇 |
综合类 | 26篇 |
预防医学 | 199篇 |
眼科学 | 51篇 |
药学 | 394篇 |
中国医学 | 50篇 |
肿瘤学 | 317篇 |
出版年
2023年 | 32篇 |
2022年 | 86篇 |
2021年 | 133篇 |
2020年 | 73篇 |
2019年 | 89篇 |
2018年 | 146篇 |
2017年 | 89篇 |
2016年 | 160篇 |
2015年 | 182篇 |
2014年 | 287篇 |
2013年 | 282篇 |
2012年 | 374篇 |
2011年 | 364篇 |
2010年 | 198篇 |
2009年 | 202篇 |
2008年 | 241篇 |
2007年 | 233篇 |
2006年 | 243篇 |
2005年 | 246篇 |
2004年 | 200篇 |
2003年 | 169篇 |
2002年 | 169篇 |
2001年 | 85篇 |
2000年 | 75篇 |
1999年 | 78篇 |
1998年 | 20篇 |
1997年 | 20篇 |
1996年 | 36篇 |
1995年 | 21篇 |
1994年 | 14篇 |
1993年 | 17篇 |
1992年 | 34篇 |
1991年 | 37篇 |
1990年 | 26篇 |
1989年 | 22篇 |
1988年 | 29篇 |
1987年 | 19篇 |
1986年 | 25篇 |
1985年 | 15篇 |
1984年 | 13篇 |
1983年 | 14篇 |
1982年 | 11篇 |
1979年 | 14篇 |
1978年 | 5篇 |
1977年 | 8篇 |
1976年 | 6篇 |
1975年 | 7篇 |
1974年 | 8篇 |
1972年 | 4篇 |
1969年 | 3篇 |
排序方式: 共有4881条查询结果,搜索用时 15 毫秒
81.
82.
83.
84.
Selective tumor kill of cerebral glioma by photodynamic therapy using a boronated porphyrin photosensitizer. 下载免费PDF全文
J S Hill S B Kahl S S Stylli Y Nakamura M S Koo A H Kaye 《Proceedings of the National Academy of Sciences of the United States of America》1995,92(26):12126-12130
The prognosis for patients with the high-grade cerebral glioma glioblastoma multiforme is poor. The median survival for primary tumors is < 12 months, with most recurring at the site of the original tumor, indicating that a more aggressive local therapy is required to eradicate the unresectable "nests" of tumor cells invading into adjacent brain. Two adjuvant therapies with the potential to destroy these cells are porphyrin-sensitized photodynamic therapy (PDT) and boron-sensitized boron neutron capture therapy (BNCT). The ability of a boronated porphyrin, 2,4-(alpha, beta-dihydroxyethyl) deuteroporphyrin IX tetrakiscarborane carboxylate ester (BOPP), to act as a photosensitizing agent was investigated in vitro with the C6 rat glioma cell line and in vivo with C6 cells grown as an intracerebral tumor after implantation into Wistar rats. These studies determined the doses of BOPP and light required to achieve maximal cell kill in vitro and selective tumor kill in vivo. The data show that BOPP is more dose effective in vivo by a factor of 10 than the current clinically used photosensitizer hematoporphyrin derivative and suggest that BOPP may have potential as a dual PDT/BNCT sensitizer. 相似文献
85.
Hye Jeong Kim Jae Woo Kim Kyu Hong Kim Ki Won Jo Jin Hon Hong Soon Koo Baik Hyun Soo Kim 《Taehan Sohwagi Hakhoe chi》2007,49(3):173-176
Afferent loop syndrome is an uncommon complication which occurs in patients with Billroth II partial gastrectomy. Clinically, the diagnosis of afferent loop syndrome may be difficult to establish and thus, depends on the finding of computed tomography, abdominal ultrasound, barium studies and hepatobiliary scan. When the diagnosis is made, most of the cases are treated by surgical operation. We present a case of 67-year-old male patient with afferent loop syndrome associated with acute pancreatitis which was treated by endoscopic drainage procedure using a nasogastric tube. 相似文献
86.
Introduction of HIV type 1 subtype E virus into South Korea 总被引:1,自引:0,他引:1
Lee JS Nam JG Kim EY Kang C Koo BK Cho HW 《AIDS research and human retroviruses》2000,16(11):1083-1087
Subtype E HIV-1 is the most prevalent strain in Southeast Asia. Although subtype B is prevalent in Korea, geographical distance and increases in travel may lead to the spread of subtype E in Korea. Therefore, we tried to identify and monitor the patterns of HIV subtype E virus introduction into Korea. The divergence of nucleotide sequences within the envelope region (V3 to V5) of Korean subtype E isolates ranged from 4.3 to 14.6% (n = 8; mean, 9.5 +/- 2.8%). In pairwise comparisons of subtype E isolates between Korea and other regions, the divergence of nucleotide sequences between 8 Korean and 16 Asian subtype E variants ranged from 1.3 to 15.2% (mean, 7.8 +/- 2.6%), whereas the divergence of nucleotide sequences between 8 Korean and 2 African variants ranged from 11.7 to 20.7% (mean, 15.4 +/- 2.2%). A phylogenetic tree showed that Korean subtype E isolates cluster with the Asian isolates but far from the African isolates. These epidemiological and molecular epidemiological data suggest that HIV-1 subtype E strains have been transmitted into Korea from endemic areas of Southeast Asia rather from Africa. 相似文献
87.
Kyoung-Woo Seo Hyoung-Mo Yang Junghan Yoon Hyo-Soo Kim Kiyuk Chang Hong-Seok Lim Byoung-Joo Choi So-Yeon Choi Myeong-Ho Yoon Seung-Hwan Lee Sung Gyun Ahn Young Jin Youn Jun-Won Lee Bon-Kwon Koo Kyung Woo Park Han-Mo Yang Jung-Kyu Han Wook-Sung Chung Hun-Jun Park Byung-Hee Hwang Eun-Ho Choo Gyu-Chul Oh Seung-Jea Tahk 《Medicine》2021,100(19)
This study evaluated the 5-year clinical outcomes of the Genoss DES, the first Korean-made sirolimus-eluting coronary stent with abluminal biodegradable polymer.We previously conducted the first-in-patient prospective, multicenter, randomized trial with a 1:1 ratio of patients using the Genoss DES and Promus Element stents; the angiographic and clinical outcomes of the Genoss DES stent were comparable to those of the Promus Element stent. The primary endpoint was major adverse cardiac events (MACE), which was a composite of death, myocardial infarction (MI), and target lesion revascularization (TLR) at 5 years.We enrolled 38 patients in the Genoss DES group and 39 in the Promus Element group. Thirty-eight patients (100%) from the Genoss DES group and 38 (97.4%) from the Promus Element group were followed up at 5 years. The rates of MACE (5.3% vs 12.8%, P = .431), death (5.3% vs 10.3%, P = .675), TLR (2.6% vs 2.6%, P = 1.000), and target vessel revascularization (TVR) (7.9% vs 2.6%, P = .358) at 5 years did not differ significantly between the groups. No TLR or target vessel revascularization was reported from years 1 to 5 after the index procedure, and no MI or stent thrombosis occurred in either group during 5 years.The biodegradable polymer Genoss DES and durable polymer Promus Element stents showed comparable low rates of MACE at the 5-year clinical follow-up. 相似文献
88.
Dong Won Park Jae Young Moon Eun Yong Ku Sun Jong Kim Young-Mo Koo Ock-Joo Kim Soon Haeng Lee Min-Woo Jo Chae-Man Lim John David Armstrong II Younsuck Koh 《Journal of Korean medical science》2015,30(4):495-501
This research aimed to investigate the changes in ethical issues in everyday clinical practice recognized by critical care nurses during two observation periods. We conducted a retrospective analysis of data obtained by prospective questionnaire surveys of nurses in the intensive care units (ICU) of a tertiary university-affiliated hospital in Seoul, Korea. Data were collected prospectively during two different periods, February 2002-January 2003 (Period 1) and August 2011-July 2012 (Period 2). Significantly fewer cases with ethical issues were reported in Period 2 than in Period 1 (89 cases [2.1%] of 4,291 ICU admissions vs. 51 [0.5%] of 9,302 ICU admissions, respectively; P < 0.001). The highest incidence of cases with identified ethical issues in both Periods occurred in MICU. The major source of ethical issues in Periods 1 and 2 was behavior-related. Among behaviorrelated issues, inappropriate healthcare professional behavior was predominant in both periods and mainly involved resident physicians. Ethical issue numbers regarding end-oflife (EOL) care significantly decreased in the proportion with respect to ethical issues during Period 2 (P = 0.044). In conclusion, the decreased incidence of cases with identified ethical issues in Period 2 might be associated with ethical enhancement related with EOL and improvements in the ICU care environment of the studied hospital. However, behaviorrelated issues involving resident physicians represent a considerable proportion of ethical issues encountered by critical care nurses. A systemic approach to solve behavior-related issues of resident physicians seems to be required to enhance an ethical environment in the studied ICU.
Graphical Abstract
相似文献89.
Ji Ho Choi Seung Hoon Lee Jae Hoon Cho Sung Wan Kim Kyu Sup Cho Soo Kweon Koo Tae-Bin Won Jeong-Whun Kim Hyo Yeol Kim Yoo Suk Kim Yoo-Sam Chung Chae-Seo Rhee 《Clinical and experimental otorhinolaryngology》2015,8(4):370-375
Objectives
To evaluate the effect of obstructive sleep apnea (OSA) surgery on long-term (5-year) subjective outcomes, including sleep disordered breathing (SDB) symptoms and other complications, in patients with OSA.Methods
We enrolled patients who underwent diagnostic polysomnography for OSA between January 2006 and December 2006 in ten hospitals. Patients either were treated for OSA or were not treated for OSA. All patients completed a brief telephone survey regarding their SDB signs and symptoms (e.g., snoring, apnea, nocturnal arousals, and daytime sleepiness), positive airway pressure (PAP) compliance, and any adverse effects of either the surgery or PAP. A positive subjective outcome for either surgery or no treatment was taken to be the alleviation of apnea, defined as a ≥50% increase in score. A positive subjective outcome (compliance) for PAP was defined as a PAP usage of ≥4 hours per night and ≥5 days per week.Results
A total of 229 patients were included in this study. Patients were divided into three groups: a surgery group (n=87), a PAP group (n=68), and a control (untreated) group (n=74). The surgery group exhibited significant improvement in all SDB symptoms compared with the control group. The long-term subjective outcomes of the surgery (52.9%) and PAP (54.4%) groups were significantly better than those of the control group (25.0%). The subjective outcome of the surgery group was not significantly different from that of the PAP group. The overall surgical complication rate was 23.0% (20 of 87) in the surgery group, and 55.0% (22 of 40) of all patients with PAP experienced adverse effects.Conclusion
The extent of SDB symptoms was consistently improved in patients with OSA at 5 years postsurgery. Information about the potential long-term subjective outcomes should be provided to patients when considering surgery. 相似文献90.
Kim JC Koo KH Lee DH Roh SA Kim HC Yu CS Kang GH 《International journal of colorectal disease》2001,16(2):102-107
Although the APC protein is known to participate in cellular proliferation and apoptosis, APC mutations have been thought to play a major role in the early stage of colorectal tumorigenesis. The somatic APC mutation of exon 15 was assessed to determine its impact on various stages of colorectal tumorigenesis. The colorectal neoplastic tissues of serial array studied included sporadic adenomas (group 1, n = 36), adenomas (group 2, n = 33), and carcinomas (group 3, n = 32) in the synchronous adenoma and carcinoma as well as sporadic carcinomas (group 4, n = 36). Aberrant DNA was detected by protein truncation test and confirmed by direct sequencing. The mutation prevalence was 36.1% in group 1, 45.5% in group 2, 59.4% in group 3, and 41.7% in group 4 with no differences among the groups. Among the 18 patients with synchronous adenoma and carcinoma, 9 had mutation in their adenomas and 12 in their carcinomas. The mutation loci and patterns did not differ in adenomas and carcinomas. Mutations in the mutation cluster region (MCR) were much more frequent than in the preceding region of MCR, i.e., 85.7% vs. 14.3%. The mutation prevalence of villous adenomas appeared greater than that of tubular adenoma (3/21 vs. 3/4). Predominant pathogenic mutations at MCR suggest that the APC mutation is implicated in all stages of colorectal tumorigenesis. 相似文献